These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22912574)

  • 1. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
    Schnell G; Loo YM; Marcotrigiano J; Gale M
    PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
    Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
    J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
    Saito T; Owen DM; Jiang F; Marcotrigiano J; Gale M
    Nature; 2008 Jul; 454(7203):523-7. PubMed ID: 18548002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.
    Malathi K; Saito T; Crochet N; Barton DJ; Gale M; Silverman RH
    RNA; 2010 Nov; 16(11):2108-19. PubMed ID: 20833746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.
    Ireton RC; Wilkins C; Gale M
    Methods Mol Biol; 2017; 1656():119-129. PubMed ID: 28808965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
    Uzri D; Gehrke L
    J Virol; 2009 May; 83(9):4174-84. PubMed ID: 19224987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
    Oshiumi H; Miyashita M; Matsumoto M; Seya T
    PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
    Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.
    Durbin AF; Wang C; Marcotrigiano J; Gehrke L
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
    Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
    J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
    Horner SM; Park HS; Gale M
    J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of RNA recognition and activation by innate immune receptor RIG-I.
    Jiang F; Ramanathan A; Miller MT; Tang GQ; Gale M; Patel SS; Marcotrigiano J
    Nature; 2011 Sep; 479(7373):423-7. PubMed ID: 21947008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
    Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
    mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RIG-I mediated hepatic innate immune signaling that controls HCV infection].
    Saito T; Gale M
    Uirusu; 2008 Dec; 58(2):105-15. PubMed ID: 19374189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIG-I in RNA virus recognition.
    Kell AM; Gale M
    Virology; 2015 May; 479-480():110-21. PubMed ID: 25749629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
    Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
    J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
    Israelow B; Narbus CM; Sourisseau M; Evans MJ
    Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity.
    Errett JS; Gale M
    Virol Sin; 2015 Jun; 30(3):163-73. PubMed ID: 25997992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.